The presence of cancer-causing viruses and faulty genes adds to the burden of cancer among people. Thus, the increased prevalence of cancer acts as a driver for the growth of the market. The high cost of proton therapy leading to high-cost treatment acts as a restraint for the growth of the proton therapy market. The increased awareness is reflected in the surging research and development in the area leading to the increased amount of clinical data coming up showcasing the benefits of treatment. Thus, the growing recognition of proton therapy acts as an opportunity for the growth of the market. The expensive treatment as compared to other technologies acts as a restraint for its growth in the market.
